RRIDs were included in the Human Genomics paper "A new bioinformatics tool to help assess the signi…" (https://t.co/K8VMf4uKxO). Thank you for making your #methodsmatter. #STMpublishing
RRIDs were included in the Human Genomics paper "A new bioinformatics tool to help assess the signi…" (https://t.co/K8VMf4uKxO). RRIDs like this improve reproducibility in scientific research. #STMpublishing #RRID
Curation and annotation of ~3000 BRCA1 variants #bioinformatics #cancer https://t.co/TuZi07t45r #
RT @SOPHiAGENETICS: Congratulations to our co-Founder Pierre Hutter for his contribution to the development of a new tool "NextProt Cancer…
RT @pascale_gaudet: Hot off the press ! Our new paper describing the annotation of functional impact of BRCA1 variants https://t.co/giKgwDu…
RT @neXtProt_news: #openaccess molecular and cellular phenotypic impact data for 3654 BRCA1 variants in neXtProt https://t.co/z3xDELulkt
RT @pascale_gaudet: Hot off the press ! Our new paper describing the annotation of functional impact of BRCA1 variants https://t.co/giKgwDu…
#openaccess molecular and cellular phenotypic impact data for 3654 BRCA1 variants in neXtProt https://t.co/z3xDELulkt
RT @SOPHiAGENETICS: Congratulations to our co-Founder Pierre Hutter for his contribution to the development of a new tool "NextProt Cancer…
RT @SOPHiAGENETICS: Congratulations to our co-Founder Pierre Hutter for his contribution to the development of a new tool "NextProt Cancer…
Congratulations to our co-Founder Pierre Hutter for his contribution to the development of a new tool "NextProt Cancer Variant Portal » which will help assess the significance of BRCA1 variants associated with breast and ovarian cancer #DataDrivenMedicine
Hot off the press ! Our new paper describing the annotation of functional impact of BRCA1 variants https://t.co/giKgwDub7n Data is in #nextprot https://t.co/ekWRk0ADGZ @neXtProt_news